Matthew Lang
CIK 1712069 · COO & GC · last filed 2026-04-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MYOV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
601 GATEWAY BLVD., SUITE 900
SOUTH SAN FRANCISCO, CA 94080
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GPCR | COO & GC | 184,614 | $22.12 | $4.08M | $0 | 1 | 2026-04-23 |
| Metsera, Inc. (MTSR) Delisted | CHIEF LEGAL OFFICER | 0 | $70.50 | $0 | $0 | 2 | 2025-11-13 |
| LYEL | Chief Business Officer | 8,125 | $9.39 | $76.3K | $0 | 3 | 2025-02-26 |
| Myovant Sciences Ltd. (MYOV) Delisted | General Counsel & Corp. Secy. | 241,158 | $26.98 | $6.51M | -$3.98M | 28 | 2023-03-10 |
Recent Filings · Page 2 of 4
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-06 | Myovant Sciences Ltd. (MYOV) Delisted | Sell (S) | −3,679 | -$89.8K | EDGAR |
| 2022-08-16 | Myovant Sciences Ltd. (MYOV) Delisted | Mixed | +93,566 | -$569.0K | EDGAR |
| 2022-07-20 | Myovant Sciences Ltd. (MYOV) Delisted | Sell (S) | −1,935 | -$24.9K | EDGAR |
| 2022-07-08 | Myovant Sciences Ltd. (MYOV) Delisted | Sell (S) | −3,702 | -$49.6K | EDGAR |
| 2022-04-21 | Myovant Sciences Ltd. (MYOV) Delisted | Sell (S) | −8,002 | -$83.6K | EDGAR |
| 2022-04-19 | Myovant Sciences Ltd. (MYOV) Delisted | Grant (A) | +111,111 | $0 | EDGAR |
| 2022-04-07 | Myovant Sciences Ltd. (MYOV) Delisted | Sell (S) | −2,436 | -$33.6K | EDGAR |
| 2022-01-06 | Myovant Sciences Ltd. (MYOV) Delisted | Sell (S) | −4,475 | -$72.8K | EDGAR |
| 2021-10-07 | Myovant Sciences Ltd. (MYOV) Delisted | Sell (S) | −6,671 | -$144.2K | EDGAR |
| 2021-07-13 | Myovant Sciences Ltd. (MYOV) Delisted | Sell (S) | −6,954 | -$149.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.